
Summary for Tradename: cozaar
|
|
Latest news for COZAARDuPont profit tops estimates27 July 2010, 10:13 pm DuPont Says Auto, Electronic Demand to Help Increase Sales in Second Half27 July 2010, 5:09 pm Merck pairs up with Chinese drugmaker Sinopharm27 July 2010, 10:58 am Teva Q2 Earnings Tops27 July 2010, 10:39 am Teva 2Q profit climbs 53 percent27 July 2010, 7:36 am DuPont Profit Tops Estimates; 2010 Forecast Raised27 July 2010, 6:35 am Cataracts linked to allergy medicine - Tue, 27 Jul 2010 PST27 July 2010, 3:20 am Teva Q2 Profit Up 53% - Update27 July 2010, 3:06 am Teva Reports Strong Second Quarter 2010 Results Driven by Growth in All Businesses27 July 2010, 1:00 am Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | COZAAR | losartan potassium | 020386 | Apr 14, 1995 | RX | No | 5,138,069*PED | Y | Feb 11, 2010 | |||
| Merck | COZAAR | losartan potassium | 020386 | Apr 14, 1995 | RX | No | 5,153,197*PED | Y | Apr 6, 2010 | |||
| Merck | COZAAR | losartan potassium | 020386 | Apr 14, 1995 | RX | No | 5,210,079*PED | Y | Nov 11, 2010 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.